Related Experiment Video
Updated: May 4, 2026

Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro
Published on: June 13, 2011
Interleukin-6 prevents NMDA-induced neuronal death via Gp130 signaling-dependent IP3R inhibition
Ao-Wang Qiu1, Qin Yang2, Song-Tao Yuan2
1Department of Ophthalmology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu Province 210029, China. qinghuailiu@163.com.
Objective:
To reveal the involvement of inositol 1,4,5-trisphosphate receptors (IP3R) and ryanodine receptors (RyR) in IL-6 prevention from neuronal apoptosis and necrosis induced by N-methyl-D-aspartate (NMDA).
Methods:
Cerebellar granule neurons (CGNs) from 8-day-old rats were exposed to IL-6 for 8 days and then stimulated with NMDA for 30 min. The 2-aminoethoxydiphenyl borate (2-APB) and dantrolene (DAN) were used to antagonize IP3R and RyR, respectively. Anti-gp130 monoclonal antibody (mAb) was employed to neutralize gp130, a 130-kDa signal-transducing β-subunit of IL-6 receptor complex. Neuronal apoptosis and necrosis were determined by TUNEL, fluorometric caspase-3 enzyme activity, annexin V-FITC/PI staining and ELISA. Western blot and real-time PCR measured IP3R1 and RyR2 expression, respectively.
Results:
IL-6 prevented the elevation of TUNEL-positive cells and caspase-3 expression and activity, and also suppressed the increase in annexin V-FITC/PI-positive cells and DNA- and histone-associated nucleosomes in cultured CGNs evoked by NMDA. These anti-apoptotic and anti-necrotic effects of IL-6 were larger on DAN-treated cells than on 2-APB-exposed neurons, since 2-APB treatment alone significantly inhibited the neuronal apoptosis and necrosis but DAN exposure alone did not alter the apoptosis and necrosis induced by NMDA. In support of these results, IL-6 downregulated IP3R1 but did not affect RyR2 expression. All these IL-6 effects were blocked by anti-gp130 mAb.
Conclusion:
IL-6 prevention from NMDA-triggered Ca2+-induced Ca2+ release-mediated apoptosis and necrosis in CGNs depends on the inhibition of IP3R channel opening and expression rather than on RyR activity. IL-6 receptor-coupled gp130 signaling mediates this neuroprotection of IL-6 resistance to neuronal apoptosis and necrosis.
Insights
Interleukin-6 (IL-6) protects neurons from N-methyl-D-aspartate (NMDA) induced cell death by inhibiting inositol 1,4,5-trisphosphate receptors (IP3R). This neuroprotection relies on gp130 signaling, not ryanodine receptors (RyR).
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Neuronal apoptosis and necrosis are critical in neurodegenerative diseases.
- Interleukin-6 (IL-6) is a cytokine with known neuroprotective roles.
- Inositol 1,4,5-trisphosphate receptors (IP3R) and ryanodine receptors (RyR) are key regulators of intracellular calcium release.
Purpose of the Study:
- To investigate the roles of IP3R and RyR in IL-6 mediated neuroprotection against N-methyl-D-aspartate (NMDA) induced cell death.
- To elucidate the signaling pathways involved in IL-6's protective effects.
Main Methods:
- Primary cultures of cerebellar granule neurons (CGNs) were treated with IL-6 and then stimulated with NMDA.
- IP3R and RyR were antagonized using 2-aminoethoxydiphenyl borate (2-APB) and dantrolene (DAN), respectively.
- Neuronal death was assessed using TUNEL, caspase-3 activity, and annexin V-FITC/PI staining.
- Expression of IP3R1 and RyR2 was analyzed via Western blot and real-time PCR.
Main Results:
- IL-6 significantly reduced NMDA-induced neuronal apoptosis and necrosis.
- The neuroprotective effects of IL-6 were more pronounced with IP3R antagonism (2-APB) than RyR antagonism (DAN).
- IL-6 downregulated IP3R1 expression but did not affect RyR2 expression.
- Anti-gp130 monoclonal antibody blocked all IL-6 mediated neuroprotective effects.
Conclusions:
- IL-6 confers neuroprotection against NMDA-induced cell death by inhibiting IP3R activity and expression, not RyR.
- gp130 signaling downstream of the IL-6 receptor mediates this neuroprotective effect.
- These findings highlight IP3R as a therapeutic target for neuroprotection.
Related Concept Videos
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
IP3/DAG Signaling Pathway
